The largest database of trusted experimental protocols

Biolux gaussia luciferase kit

Manufactured by New England Biolabs

The BioLux® Gaussia Luciferase Kit is a laboratory tool that utilizes the bioluminescent properties of the Gaussia luciferase enzyme. This kit provides the necessary components to detect and measure Gaussia luciferase activity in various experimental settings.

Automatically generated - may contain errors

2 protocols using biolux gaussia luciferase kit

1

Transient Transfection Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transiently transfected and incubated at 37°C for 24 hours. For hypoxia-induction studies, transfected cells were incubated for 5 hours under standard conditions followed by a 24-hour incubation in anaerobic or hypoxic chambers as indicated. For each construct, three separate wells were transfected in parallel for HEK 293T and MCF7 cells. In case of Jurkat cells, three wells were seeded in parallel originating from the same nucleofected culture. Luciferase activity was determined from diluted samples using the BioLux® Gaussia Luciferase Kit (New England Biolabs) in combination with a Modulus single-tube luminometer (Turner Biosystems, Sunnyvale, CA) or Synergy H1 hybrid plate reader (BioTek, Winooski, VT) with a 5-sec integration time. Background luminescence measured from the supernatant of mock-transfected cells was subtracted from the raw luminescence values. Fold-induction was calculated by dividing the background-subtracted luminescence values of each induced sample by the average value of the three corresponding uninduced samples.
+ Open protocol
+ Expand
2

Evaluating IL-27's Anti-Viral Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-27 anti-viral activity was tested against vaccinia virus and mouse cytomegalovirus (MCMV) infection. Resident peritoneal macrophages were treated overnight with 100 ng/ml IL-27 and then infected with a GFP-expressing vaccinia virus for 6hrs and infection was measured by flow cytometry. For MCMV experiments, resident peritoneal macrophages were first treated with 1, 10, or 100 ng/ml of IL-27 or 10 ng/ml of IFNγ for 6hrs. Then, media with the cytokines was removed, and macrophages were infected with MCMV-3DR, a gaussia luciferase-expressing MCMV (kindly provided by Martin Messerle, Hannover Medical School), at moi=0.1. Supernatants from these macrophage cultures were collected at 24, 48, and 72hrs post-infection and used to infect M2-10B4 fibroblasts. Luciferase activity in the supernatant of infected fibroblasts was determined 18 hr post-infection using the BioLux Gaussia Luciferase kit (New England Biolabs) and a Mithras LB 940 plate reader (Berthold).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!